Margaret Plocek, MD
Surgery · Liverpool, NYNPI 1508965187
Payments from drug & device makers
Across 60 payments — averaging $24.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$197
- Paratek Pharmaceuticals, Inc.$161
- Braintree Laboratories, Inc.$135
- Solventum Corporation$128
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$123
- AbbVie$103
- plus $605 from 15 others
What the payments were for
- Food & beverage$1,453100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 3 | $197 |
| Paratek Pharmaceuticals, Inc. | 3 | $161 |
| Braintree Laboratories, Inc. | 6 | $135 |
| Solventum Corporation | 4 | $128 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $123 |
| AbbVie | 5 | $103 |
| Merck | 7 | $99 |
| Kerecis Limited | 3 | $63 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $54 |
| Ferring Pharmaceuticals Inc. | 3 | $51 |
| Hydrofera LLC | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Medtronic | 2 | $43 |
| Intuitive Surgical | 1 | $40 |
| Biom'up France SAS | 1 | $30 |
| Tactile Systems Technology Inc | 2 | $30 |
| Mimedx Group, Inc. | 1 | $25 |
| KCI USA, Inc. | 1 | $24 |
| Convatec Inc. | 1 | $22 |
| Acelrx Pharmaceuticals, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$125
How this compares
$1,453 in reported general payments places this provider in the 50th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 33 | $583 |
| Doxycycline Monohydrate | 27 | $471 |
| Gentamicin Sulfate | 17 | $290 |
| Doxycycline Hyclate | 29 | $241 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $232 |
| Levofloxacin | 27 | $202 |
| Ciprofloxacin Hcl | 18 | $81 |
| Mupirocin | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other surgery in Liverpool
- Atul MainiLiverpool$104K
- Vinod BalachandranNew York$3M
- Stephanie GoffNew York$2.7M
- Alice WeiNew York$2.3M
- Cheguevara AfanehNew York$1.4M
- Thom LoreeBuffalo$1M
- Ajay PanchalAmherst$893K
- Flavio Malcher Martins de OliveiraNew York$814K
- Bonnie LonzeNew York$650K
- Stephen GoldstoneNy$647K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.